What is AliveCor?
Headquartered in Mountain View, California, AliveCor specializes in the development of sophisticated medical software and portable diagnostic devices. Its flagship offerings, including the KardiaMobile 6L and KardiaMobile Card, empower users to record clinical-grade EKGs and detect common arrhythmias with unprecedented ease. By bridging the gap between consumer-grade wearables and professional medical diagnostics, the company has carved out a unique market position that integrates seamlessly into the modern telehealth ecosystem, providing actionable health data to both patients and clinicians.
How much funding has AliveCor raised?
AliveCor has raised a total of $154.6M across 7 funding rounds:
Series A
$3.3M
Series B
$10.5M
Series C
$20M
Series D
$30M
Debt
$20M
Other Financing Round
$5.8M
Series E
$65M
Series A (2011): $3.3M with participation from Qualcomm Ventures, Oklahoma Life Science Fund, and Burrill & Co.,
Series B (2012): $10.5M led by Khosla Ventures, Oklahoma Life Science Fund, Burrill & Co.,, and Qualcomm Ventures
Series C (2016): $20M supported by WP Global Partners
Series D (2017): $30M featuring Omron Healthcare and Mayo Clinic
Debt (2019): $20M backed by Oxford Finance
Other Financing Round (2019): $5.8M, investors not publicly disclosed
Series E (2020): $65M led by BOLD Capital Partners, Qualcomm Ventures, WP Global Partners, OMRON Corporation, and Khosla Ventures
Key Investors in AliveCor
Qualcomm Ventures
A global technology investment arm that focuses on wireless innovation, semiconductor advancements, and intelligent computing platforms to accelerate connected device ecosystems.
Khosla Ventures
A prominent venture capital firm providing strategic guidance and capital to entrepreneurs developing breakthrough technologies across health, AI, and enterprise sectors.
Mayo Clinic
A world-renowned nonprofit healthcare organization that integrates clinical practice, education, and research to drive medical innovation and patient care excellence.
What's next for AliveCor?
With a robust history of capital infusion, AliveCor is well-positioned to scale its KardiaCare platform and expand its footprint in the global digital health market. The strategic focus moving forward likely involves deepening its integration with existing healthcare infrastructure and enhancing its AI-driven diagnostic capabilities. As the company continues to leverage its substantial investment backing, it remains focused on refining its product suite to address the growing demand for decentralized, proactive cardiac monitoring solutions, ensuring long-term sustainability and market leadership in the evolving health-tech landscape.
See full AliveCor company page
